Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Noah Lee 2025 Sep 19, 12:10

Fed Rate Cut: Michael Strain Warns of Potential Policy Reversal in 2026

Ava Grace 2025 Sep 19, 10:10

Fed Rate Cut: Stock Market Outlook Amid Economic Uncertainty

Ghko B 2025 Sep 18, 16:00

SNAP Stock Jumps 5% Today: Why Snap Inc (SNAP) Stock Is Trading Up?

stocks
Frances Wang 2025 Sep 18, 16:00

Trending stocks to watch in Saudi Arabia: QUBT Stock, MSTR, NBIS

stocks
Frances Wang 2025 Sep 18, 16:00

Gold CFD Brokers in Saudi Arabia: markets.com, FP Markets, Tickmill

commodity
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Latest news

Show more
Emma Rose 2025 Sep 19, 15:20

Federal Reserve Reform on the Horizon: Price Stability Act Sparks Debate on Central Bank's Mission

Ava Grace 2025 Sep 19, 14:20

Market Review: Fed Rate Cut and Global Economic Trends

Noah Lee 2025 Sep 19, 11:20

US Senators Target Russian Energy Exports with 'Shadow Fleet' Sanctions

Sophia Claire 2025 Sep 19, 04:20

Bank of Japan Holds Rates Steady, Plans to Start Selling ETFs

Liam James 2025 Sep 18, 15:20

Hong Kong Gold Theft Recovered: A Sign of a Growing Global Trend?

Ava Grace 2025 Sep 18, 15:20

US Initial Jobless Claims Fall: A Rebound or a Sign of Stability?

Sophia Claire 2025 Sep 18, 14:20

White House Reacts to Fed Rate Cut: Implications and Analysis

Sophia Claire 2025 Sep 18, 13:20

Swiss Gold Exports to US Plunge Amid Tariff Confusion

Info

Spread

0.70

Spread (%)

0.6150 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

141563658240

Shares Outstanding

1240806916

Earnings Date (Next)

2013-01-28

Div Yield

2025-09-29

Ex-Dividend Date

2025-09-15

Forward annual dividend rate

3.16

Forward annual dividend yield

0.0277

EPS

5.04

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 18, 16:00

Gold Price in Saudi Arabia Falls Today: How to Trade Gold CFDs (XAU/USD)?

Commodities
Frances Wang 2025 Sep 18, 16:00

KULR Stock Rises 4% Today: How to Start Trading KULR Stock CFDs in KSA?

Stocks
Frances Wang 2025 Sep 18, 16:00

ETH Price Is Up: Step-by-step Guide for Trading Crypto CFDs in Saudi Arabia

Crypto
Trustpilot